TsGRM Genetiko PAO Dividend Coverage

What does TsGRM Genetiko PAO do? TsGRM Genetiko PAO generates revenue through medical genetic services provided to doctors and patients via its four specialized laboratories. The company offers complex genetic diagnostics for hereditary diseases and reproductive disorders through its Next-Generation Sequencing (NGS) laboratory, Non-Invasive Prenatal Testing (NIPT) laboratory, Oncogenetics laboratory, and Genotyping laboratory. These services are delivered to healthcare professionals and individuals seeking genetic analysis. The firm's laboratory and production complexes form the core of its service delivery model, focusing on diagnostic solutions for medical genetics. TsGRM Genetiko PAO's primary customers are doctors who order genetic tests for their patients and patients directly seeking genetic diagnostics. The company's services include hereditary disease diagnostics and reproductive disorder assessments, which are conducted in its dedicated laboratory facilities. The firm's business model centers on providing specialized genetic testing services through its internal laboratory infrastructure without external partnerships or additional product lines. The company operates exclusively within the medical genetic services sector, delivering diagnostic solutions through its four laboratory divisions. Revenue is derived from the execution of genetic tests across all laboratory types, with no mention of additional product lines or external collaborations. The firm's structure is defined by its internal laboratory network, which serves both medical professionals and end patients. TsGRM Genetiko PAO is one of the most popular companies on Eulerpool.